Meet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
Integrating development, analytical, and manufacturing knowledge into regulatory-ready CMC packages that support approval pathways across the product lifecycle.
Regulatory success depends on more than generating development, analytical, and manufacturing data. That information must be translated into clear, compliant, and submission-ready CMC documentation that meets global regulatory expectations.
We integrate Regulatory CMC support throughout the product lifecycle, aligning development, analytical, manufacturing, and quality activities with regulatory requirements. By combining technical expertise with regulatory insight, we help customers navigate key regulatory milestones, support submissions, and reduce compliance risks.
We help customers navigate regulatory pathways by aligning development and manufacturing activities with submission requirements. Early regulatory planning helps establish a stronger foundation for future filings and regulatory interactions.
We support the preparation and review of CMC sections for regulatory submissions, including IND, IMPD, NDA, ANDA, and related filings. By consolidating information generated across development, analytical, and manufacturing functions, we help create clear and consistent regulatory packages.
Whether you're planning an IND submission, advancing through clinical development, addressing regulatory deficiencies, or preparing for commercialization, we can help strengthen your Regulatory CMC strategy.
Our teams review existing CMC documentation to identify gaps, inconsistencies, and areas of regulatory risk. We also support responses to agency questions and deficiencies through coordinated technical and regulatory expertise.
We support comprehensive risk assessments for elemental impurities, genotoxic impurities, and nitrosamines, helping customers address evolving regulatory expectations and strengthen compliance strategies.
